ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,837, issued on Jan. 20, was assigned to FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA (FISABIO) (Valencia, Spain).
"Peptide for use in the prevention and/or treatment of a disease caused by a virus affecting the respiratory tract" was invented by Alejandro Mira Obrador (Valencia, Spain), Maria de los Desamparados Ferrer Garcia (Valencia, Spain), Paula Corell Escuin (Valencia, Spain) and Francisco Javier Lopez Labrador (Valencia, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Peptides and pharmaceutical compositions comprising the same are described for use in the treatment and/or prevention of a...